home / stock / mbrx / mbrx quote
Last: | $4.28 |
---|---|
Change Percent: | -0.93% |
Open: | $4.32 |
Close: | $4.28 |
High: | $4.4199 |
Low: | $4.28 |
Volume: | 10,405 |
Last Trade Date Time: | 04/17/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$4.28 | $4.32 | $4.28 | $4.4199 | $4.28 | 10,405 | 04-17-2024 |
$4.28 | $4.55 | $4.28 | $4.7399 | $4.28 | 15,943 | 04-16-2024 |
$4.46 | $4.6 | $4.46 | $4.66 | $4.32 | 20,009 | 04-15-2024 |
$4.6269 | $4.82 | $4.6269 | $4.97 | $4.54 | 18,602 | 04-12-2024 |
$4.77 | $5.06 | $4.77 | $5.1299 | $4.65 | 27,798 | 04-11-2024 |
$5.2 | $5.69 | $5.2 | $5.91 | $4.81 | 31,145 | 04-10-2024 |
$5.23 | $5.09 | $5.23 | $5.2899 | $5.02 | 22,165 | 04-09-2024 |
$5.05 | $5.12 | $5.05 | $5.3399 | $5 | 53,147 | 04-08-2024 |
$5.2 | $4.96 | $5.2 | $5.5 | $4.96 | 39,769 | 04-05-2024 |
$5.3 | $5.29 | $5.3 | $5.31 | $5.05 | 15,757 | 04-04-2024 |
$5.25 | $5.33 | $5.25 | $5.6299 | $5.09 | 46,587 | 04-03-2024 |
$5.45 | $5.7 | $5.45 | $5.7 | $5.18 | 28,686 | 04-02-2024 |
$5.67 | $5.79 | $5.67 | $6.09 | $5.67 | 27,055 | 04-01-2024 |
$5.91 | $5.58 | $5.91 | $6.2348 | $5.179 | 78,010 | 03-29-2024 |
$5.91 | $5.58 | $5.91 | $6.2348 | $5.179 | 78,010 | 03-28-2024 |
$5.54 | $4.8 | $5.54 | $5.688 | $4.75 | 89,261 | 03-27-2024 |
$4.68 | $4.95 | $4.68 | $4.99 | $4.34 | 92,008 | 03-26-2024 |
$5.25 | $6 | $5.25 | $6 | $4.65 | 915,721 | 03-25-2024 |
$5.7047 | $5.56 | $5.7047 | $6.24 | $5.3 | 98,642 | 03-22-2024 |
$6.63 | $6.105 | $6.63 | $7.3485 | $6.105 | 671,289 | 03-21-2024 |
News, Short Squeeze, Breakout and More Instantly...
Moleculin Biotech Inc. Company Name:
MBRX Stock Symbol:
NASDAQ Market:
Moleculin Biotech Inc. Website:
Moleculin Announces Presentation of Positive Data Demonstrating High Anti-Cancer Activity of Annamycin and Non-Cardiotoxic Properties PR Newswire Annamycin demonstrated to be a more potent inhibitor of topoisomerase II-alpha and II-beta while remaining inactive against establi...
2024-03-29 06:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Moleculin to Present at the MedInvest Biotech & Pharma Investor Conference Moleculin to Present at the MedInvest Biotech & Pharma Investor Conference PR Newswire Live webcast on Thursday, April 4 th at 4:10 PM ET HOUSTON , March 28, 2024 /...